logo

Quick Facts

Share SHARE

Realty Income Corp. (O) announced the company estimates FFO per share for 2017 of $3.00 to $3.06. The company also estimates AFFO per share for 2017 of $3.00 to $3.06. FFO per share for the quarter ended March 31, 2017 increased 4.4% to $0.71, as compared to $0.68 for the same quarter in 2016. AFFO...

Edwards Lifesciences Corp. (EW) announced, for full year 2017, the company is narrowing sales guidance to $3.2 to $3.4 billion, from $3.0 to $3.4 billion. The company is also raising its estimate for 2017 adjusted earnings per share to $3.43 to $3.55, from $3.30 to $3.45. For the second quarter of...

TSYS (TSS) announced the company now expects fiscal 2017 adjusted EPS attributable to shareholders in a range of $3.16 to $3.26; and net revenue in the range of $3.295 to $3.395 billion. "As a result of our strong first quarter performance and the six-month delay in the effective date of the CFPB's...

United States Steel Corp. (X) announced it expects 2017 net earnings of approximately $260 million, or $1.50 per share, and adjusted EBITDA of approximately $1.1 billion. The company believes market conditions will change, and as changes occur during the balance of 2017, it expects these changes to be...

Deckers Brands (DECK) announced its Board has initiated a process to review a broad range of strategic alternatives. The review process includes an exploration and evaluation of strategic alternatives to enhance stockholder value, which may include a sale or other transaction. The company has retained...

French luxury goods company Kering SA (PPRUY.PK, PPRUF.PK) Tuesday reported first-quarter sales of 3.57 billion euros, up 31.2 percent from 2.72 billion euros last year. On a comparable basis, sales were up 28.6 percent. Sales at the company's luxury segment rose 34.0 percent to 2.42 billion euros...

AstraZeneca (AZN.L) announced the European Commission has granted full marketing authorisation for Tagrisso (osimertinib) 40mg and 80mg once-daily tablets for the treatment of adult patients with locally-advanced or metastatic epidermal growth factor receptor T790M mutation-positive non-small cell lung...

Pentair plc (PNR) reported that its net income for the first quarter 2017 declined to $87.8 million and $0.48 per share from $107.4 million and $0.59 per share last year. First quarter 2017 earnings per share from continuing operations were $0.44 compared to $0.50 in the first quarter of 2016. On...

Corning Inc. (GLW) reported a turnaround to profit in the first quarter on higher revenues. Both revenue and core earnings per share for the quarter beat analysts' estimates. First-quarter net income attributable to the company was $86 million or $0.07 per share, compared to net loss of $368 million...

India-based software services company Wipro Ltd. (WIT) reported Tuesday that its fourth-quarter net income attributable to equity holders was 22.61 billion Indian rupees or $349 million, an increase of 1% from last year's 22.38 billion rupees. Earnings per share were 9.32 rupees or $0.14, higher than...

Lantheus Holdings Inc. (LNTH) and GE Healthcare (GE) said they have signed a definitive license agreement for the continued Phase III development and worldwide commercialization of flurpiridaz F 18. Flurpiridaz F 18 is an investigational positron emission tomography or PET myocardial perfusion imaging...

Freeport-McMoRan Inc. (FCX) Tuesday announced a turnaround to profit in the first quarter to $228 million from loss of $4.184 billion last year. On a per share basis, earnings were $0.16, compared to loss of $3.35 a year ago. The results were impacted by reduction in total costs and expenses to $2.761...

Caterpillar Inc. (CAT) reported Tuesday that its first-quarter profit attributable to common shareholders declined to $192 million from last year's $271 million. Earnings per share were $0.32, lower than $0.46 a year ago. Excluding restructuring costs, first-quarter 2017 profit per share was $1.28,...

McDermott International Inc. (MDR) reported a turnaround to profit in the first quarter despite lower revenues. Looking ahead, the company raised its earnings outlook for fiscal 2017. The company's net income for the first quarter was $21.9 million or $0.08 per share, compared to net loss of $2.2...

Allergan plc (AGN) announced it has been granted marketing authorization from the U.S. FDA for TrueTear Intranasal Tear Neurostimulator, the only FDA-cleared device developed to temporarily increase tear production during neurostimulation in adult patients. TrueTear is a handheld stimulator with daily...

Follow RTT